Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)79212-6 ◽

2008 ◽

Vol 2008 ◽

pp. 43-44

Author(s):

J.L. Leahy

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Initial Combination Therapy ◽

Initial Combination

Download Full-text

Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc07-0627 ◽

2007 ◽

Vol 30 (8) ◽

pp. 1979-1987 ◽

Author(s):

B. J. Goldstein ◽

M. N. Feinglos ◽

J. K. Lunceford ◽

J. Johnson ◽

D. E. Williams-Herman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Initial Combination Therapy ◽

Initial Combination

Download Full-text

Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)79145-5 ◽

2008 ◽

Vol 2008 ◽

pp. 10-11 ◽

Author(s):

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Initial Combination Therapy ◽

Initial Combination

Download Full-text

Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus

Expert Review of Endocrinology & Metabolism ◽

10.1586/17446651.3.1.13 ◽

2008 ◽

Vol 3 (1) ◽

pp. 13-19 ◽

Author(s):

Tina Vilsbøll

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Initial Combination Therapy ◽

Initial Combination

Download Full-text

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2010.02589.x ◽

2011 ◽

Vol 65 (2) ◽

pp. 154-164 ◽

Author(s):

K. H. Yoon ◽

G. R. Shockey ◽

R. Teng ◽

G. T. Golm ◽

P. R. Thakkar ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Cell Function ◽

Β Cell ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Initial Combination Therapy ◽

Β Cell Function ◽

Initial Combination

Download Full-text

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc06-0703 ◽

2006 ◽

Vol 29 (12) ◽

pp. 2632-2637 ◽

Author(s):

P. Aschner ◽

M. S. Kipnes ◽

J. K. Lunceford ◽

M. Sanchez ◽

C. Mickel ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2012.741591 ◽

2012 ◽

Vol 13 (18) ◽

pp. 2663-2671 ◽

Author(s):

Rosemarie Lajara

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment

Journal of Clinical Medicine Research ◽

10.14740/jocmr3558 ◽

2019 ◽

Vol 11 (2) ◽

pp. 89-97

Author(s):

Keisuke Okamura ◽

Kazuyuki Shirai ◽

Motoyasu Miyazaki ◽

Tetsu Okuda ◽

Yosuke Takamiya ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Dipeptidyl Peptidase ◽

Poor Glycemic Control ◽

Combination Drug ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Patient Enrollment

Download Full-text

Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.41343 ◽

2018 ◽

Vol 25 (6) ◽

pp. 512-520 ◽

Author(s):

Daisaku Masuda ◽

Takuya Kobayashi ◽

Masami Sairyou ◽

Hiroyuki Hanada ◽

Tohru Ohama ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Lipoprotein Metabolism ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients

Medicine ◽

10.1097/md.0000000000007638 ◽

2017 ◽

Vol 96 (36) ◽

pp. e7638 ◽

Author(s):

Fei Wang ◽

Yuan He ◽

Rong Zhang ◽

Qiang Zeng ◽

Xiaolan Zhao

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.790365 ◽

2013 ◽

Vol 14 (9) ◽

pp. 1111-1118 ◽

Author(s):

Kiyomi Masuda ◽

Kazutaka Aoki ◽

Kazunari Kamiko ◽

Masahiro Takihata ◽

Yuzuru Ito ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Day Treatment ◽

Dipeptidyl Peptidase ◽

Inadequate Response ◽

Dipeptidyl Peptidase 4 ◽

Glucosidase Inhibitors ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text